Julia Tevini

Dr. Julia Tevini is a research scientist at the Salk Institute specializing in receptor biochemistry and tumor metabolism. She holds both MSc and PhD degrees and maintains an active research program with 28 publications spanning from 2019 to 2025.

Her educational background includes a Master of Science (MSc) and Doctor of Philosophy (PhD), though specific institutions and dates are not provided in the available information.

Dr. Tevini's research spans multiple interconnected fields in biochemical and molecular analysis. Her primary interests include:

• Biochemistry and Molecular Biology - with focus on receptor signaling mechanisms
• Metabolomics - particularly in relation to disease states
• Tumor Metabolism - investigating metabolic alterations in cancer
• Lipidomics - studying lipid profiles in various conditions
• Epigenetics - examining DNA methylation patterns as biomarkers
• Neuroscience - particularly related to Alzheimer's disease mechanisms

Her publication record demonstrates significant interdisciplinary work, bridging biochemistry, oncology, neuroscience, and analytical techniques. Key research themes include metabolite signatures in various diseases, epigenetic biomarkers for cancer risk assessment, and molecular mechanisms in neurodegenerative conditions. She frequently employs advanced analytical techniques such as tandem mass spectrometry and high-performance liquid chromatography in her research.

Dr. Tevini has been involved in significant research projects, including a completed project on 'Non-alcoholic fatty liver disease and hepatocellular cancer: Regulation of apoptosis by the lipid droplet proteome and lipidome' (2020-2021). Her collaborative approach is evident in her multi-author publications across various journals including Neural Regeneration Research, JCI Insight, Communications Medicine, and International Journal of Molecular Sciences.